Star Combo Pharma Ltd.'s market cap is currently AU$31.05M. The company's EPS TTM is AU$0.037; its P/E ratio is 5.91; and it has a dividend yield of 1.61%. Star Combo Pharma Ltd. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in AUD
Star Combo Pharma Ltd. Earnings and Revenue History
